RhumbLine Advisers

RhumbLine Advisers’s Biodexa Pharmaceuticals BDRX Stock Holding History

RhumbLine Advisers’s Portfolio BDRX Stock Details BDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$59	Sell
2025 Q1	$414	Buy
2024 Q4	$628	Sell
2024 Q3	$1.7K	Buy
2024 Q2	$2.42K	Buy
2024 Q1	$806	Hold
2023 Q4	$1.33K	Buy
2023 Q3	$1.08K	Buy
2023 Q2	–	Hold